Home > Food & Beverages > Food Additives > Texturizers and Thickeners > Yeast Beta-glucan Market
Yeast Beta-glucan Market size valued at USD 165 million in 2022 and is anticipated to expand at 9.5% CAGR from 2023 to 2032, driven by rising meat consumption globally.
Global meat consumption per person is expected to rise 0.3% annually to 35.4 kg in retail weight equivalent by 2030, according to the OECD-FAO agriculture outlook, resulting from rapid urbanization. Beta glucans have emerged as an important animal feed ingredient for animal nutrition resulting from the rising interest in functional foods and the new laws that forbid the use of antibiotics that promote growth, resulting in rising product demand as an additive in animal feed products, which is a major factor supporting the market growth.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Yeast Beta-glucan Market Size in 2022: | USD 165 Million |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 9.6% |
2032 Value Projection: | USD 409 Million |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 278 |
Tables, Charts & Figures: | 434 |
Segments covered: | Form, Purity, Application, Region |
Growth Drivers: | |
Pitfalls & Challenges: |
The extraction of yeast beta glucan from spent brewer's yeast and baker's yeast is not an expensive method but recovering the product from the produced extract is costly, which may hamper product adoption. However, various technologies for the manufacturing and purification of yeast-glucan have been developed, and new techniques are constantly being studied. Strong investments in R&D to develop cost-effective extraction methods are also expected to help manufacturers overcome this restraint in the coming years.
The yeast beta-glucan market size from soluble segment is slated to record over 9% CAGR through 2032. Changing lifestyles and the rising popularity of premium beers internationally are boosting the use of soluble yeast for fermentation in beer production. For instance, in 2021, the EU Member States produced 33.1 billion liters of alcoholic beer and around 1.7 billion liters of beer with less than 0.5% alcohol and no alcohol.
On basis of application, the yeast beta-glucan market share from food & beverage segment is estimated to amass a valuation of over USD 158.5 million by 2032, attributed to the rising popularity and awareness of food products fortified with immune-boosting components since the onset of the COVID -19 pandemic. Furthermore, the continuously rising consumption of ready-to-eat bakery items and frozen bakery products has increased the utilization of baker’s yeast as an essential ingredient.
Asia Pacific yeast beta glucan industry revenue is likely to reach USD 80 million by 2032, owing to the rising food and meat consumption in densely populated areas. Furthermore, growing awareness of the product’s health benefits has encouraged its use for a variety of therapeutic purposes in key nations, such as Japan, China, and India, thereby driving regional revenue. For instance, a clinical study published in BMJ Neurology Open in March 2022 found that children with autism spectrum disorder showed improved behavior and learning ability after consuming yeast beta glucan.
By purity, the 70% yeast beta-glucan market is projected to surpass USD 138.5 million in revenue by 2032, due to its widespread use in the production of high-quality organic cosmetic ingredients. Additionally, customers are increasingly opting for higher-quality ingredients, particularly in Middle Eastern nations such as the UAE, which is emerging as a key revenue hub for the cosmetics business. Moreover, the expanding population and the booming tourism sector are also slated to drive the market revenue.
Some of the major enterprises operating in the market include
These firms usually engage in strategic efforts, such as acquisitions, partnerships, and product portfolio expansion, to enhance their market standing. For instance, in August 2021, yeast extract manufacturer Angel Yeast formed a joint venture firm to acquire Shandong Bio Sukeen CO., Ltd., a state-owned high-tech enterprise to optimize its production capacity and further consolidate and improve its position in the industry.
Several studies discovered that beta glucan has a significant immunomodulatory impact, which enhances the cellular pattern engaged in the infectious process and decreases the cytokines involved in the inflammatory course obtained from COVID-19. As a result, beta glucans were found to be effective as immune adjuvants to boost immune response. Subsequently, the increasing use of yeast beta glucan by the pharmaceutical sector has positively influenced business growth during the pandemic.
Click here to Buy Section of this Report
Market, By Form
Market, By Purity
Market, By Application
The above information has been provided for the following regions and countries: